Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function.

Authors:
Wang X; Wang J; Ying C; Xing Y; Su X and 1 more

Journal:
BMC Pharmacol Toxicol

Publication Year: 2024

DOI:
10.1186/s40360-023-00730-6

PMCID:
PMC10765888

PMID:
38173037

Journal Information

Full Title: BMC Pharmacol Toxicol

Abbreviation: BMC Pharmacol Toxicol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateAll experimental studies as approved by the Ethics Committee of Xi’an Medical College (permit No. XYLS2019001). Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding The National Science Foundation of China (No. 81900408), Natural Science Basic Research Plan in Shaanxi Province of China (2021JQ-779), Xi’an Medical College Doctor’s Program (2020DOC08) and the fifth batch of key disciplines of Xi’an Medical College (12202305) provided funding for the study."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025